Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis
Authors
Keywords
-
Journal
IMMUNOLOGY
Volume 139, Issue 4, Pages 494-502
Publisher
Wiley
Online
2013-03-13
DOI
10.1111/imm.12096
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulatory T Cells Exhibit Decreased Proliferation but Enhanced Suppression After Pulsing With Sirolimus
- (2012) K. Singh et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers
- (2012) Megan E. Himmel et al. IMMUNOLOGY
- Immunomodulatory synergy by combining atorvastatin and rapamycin in the treatment of experimental autoimmune encephalomyelitis (EAE)
- (2012) Zhenfei Li et al. JOURNAL OF NEUROIMMUNOLOGY
- RORγt-dependent IL-17A-producing cells in the pathogenesis of intestinal inflammation
- (2012) T Kanai et al. Mucosal Immunology
- The JNK Inhibitor XG-102 Protects against TNBS-Induced Colitis
- (2012) Kirstin Reinecke et al. PLoS One
- Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells
- (2011) H.-J. Shin et al. BLOOD
- Intestinal homeostasis and its breakdown in inflammatory bowel disease
- (2011) Kevin J. Maloy et al. NATURE
- The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
- (2011) Greg M Delgoffe et al. NATURE IMMUNOLOGY
- Allospecific Regulatory Effects of Sirolimus and Tacrolimus in the Human Mixed Lymphocyte Reaction
- (2011) Josh Levitsky et al. TRANSPLANTATION
- Inflammatory Bowel Disease
- (2010) Arthur Kaser et al. Annual Review of Immunology
- The Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and Metabolism
- (2010) Jonathan D. Powell et al. IMMUNITY
- Heme oxygenase-1 upregulation improves lipopolysaccharide-induced acute lung injury involving suppression of macrophage migration inhibitory factor
- (2010) Hui Yin et al. MOLECULAR IMMUNOLOGY
- Novel cytokine-targeted therapies and intestinal inflammation
- (2009) Maximilian J Waldner et al. CURRENT OPINION IN PHARMACOLOGY
- Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice
- (2009) J. A. Emamaullee et al. DIABETES
- Biological Therapies for Inflammatory Bowel Diseases
- (2009) Paul Rutgeerts et al. GASTROENTEROLOGY
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
- (2009) Makoto Miyara et al. IMMUNITY
- Regulation of TH17 cells in the mucosal surfaces
- (2009) Daniel Mucida et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Foxp3+ Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease
- (2009) Nicola Eastaff-Leung et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Inflammatory bowel disease: review from the aspect of genetics
- (2009) Shunji Ishihara et al. JOURNAL OF GASTROENTEROLOGY
- All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis
- (2009) Aiping Bai et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs
- (2009) K. Bocian et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Differential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to Rapamycin
- (2009) Laura Strauss et al. PLoS One
- Interleukin-17 in transverse myelitis and multiple sclerosis
- (2008) J GRABER et al. JOURNAL OF NEUROIMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started